A breakthrough for those with inoperable lung cancer.
Pharmac is funding a new immunotherapy medicine, called Imfinzi for those with New Zealand's deadliest cancer.
It's the first medicine of its kind funded for lung cancer and will be available for anyone to access.
Lung Foundation CEO Philip Hope says this is a massive step forward in the fight against cancer.
He says the drug gives patients diagnosed with stage 3 non-small cell lung cancer a good option when undergoing treatment.
LISTEN ABOVE
Take your Radio, Podcasts and Music with you
